Chris Aiken, MD

What We Learned in 2022

January 8, 2023

Chris Aiken, MD and Kellie Newsome, PMHNP

Top psychiatric findings from the 2022 Carlat Report

CLINICAL UPDATE

Viibryd Goes Generic, But Is It Worth Prescribing?

January 1, 2023

Chris Aiken, MD

Chris Aiken, MD. Editor-in-Chief of The Carlat Psychiatry Report. Practicing psychiatrist, Winston-Salem, NC. Dr. Aiken has no financial relationships with companies related to this material.

Goodbye Viibryd, hello vilazodone. This novel medication has missed the mark in a lot of trials, but it still has a narrow niche in the crowded field of antidepressants.

Breastfeeding and Psychiatric Medications

December 19, 2022

Chris Aiken, MD and Kellie Newsome, PMHNP

The FDA has a new rating system for breastfeeding risks with medications. We look at what that changes for psychotropics.

Pregnancy and Psychiatric Medications

December 12, 2022

Chris Aiken, MD and Kellie Newsome, PMHNP

Updates on the management of psych meds during pregnancy and breastfeeding, with help from Anita Clayton, MD

Pregnancy and PMDD at the Mood Summit

December 5, 2022

Chris Aiken, MD and Kellie Newsome, PMHNP

This podcast brings you up to date on how to manage premenstrual dysphoric disorder and safe prescribing during pregnancy.

Antidepressants and Bipolar at the Mood Summit

November 21, 2022

Chris Aiken, MD and Kellie Newsome, PMHNP

Dr. Joe Goldberg gathered the latest evidence on antidepressants in bipolar disorder at the 9th annual Mood Disorders Summit, and we summarize his findings.

Throwback Thursday: Lithium’s Medical Benefits

November 10, 2022

Chris Aiken, MD and Kellie Newsome, PMHNP

Lithium has hidden health benefits against stroke, cancer, dementia, and even the coronavirus.

Psychopharm Commandment 5: Benzos Opioids

November 7, 2022

Chris Aiken, MD and Kellie Newsome, PMHNP

Benzos are never safe with opioids, but we clarify when the risk is lower and when the combo is best avoided.

The Benzodiazepine-Stimulant Combo: What Could Go Wrong?

September 25, 2022

Chris Aiken, MD

Chris Aiken, MD. Editor-in-Chief, The Carlat Psychiatry Report. Practicing psychiatrist, Winston-Salem, NC. Dr. Aiken, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

Neurotoxicity, substance use disorders, even traffic accidents can arise from this controversial combination. We look at how to handle it in practice, including how to reduce the use and when the combination might be OK to continue.

CLINICAL UPDATE

A Diet for ADHD

September 25, 2022

Chris Aiken, MD and Uma Naidoo, MD

Chris Aiken, MD. Editor-in-Chief, The Carlat Psychiatry Report.

Uma Naidoo, MD. Director of Nutritional and Metabolic Psychiatry, Massachusetts General Hospital (MGH); Director of Nutritional & Lifestyle Psychiatry, MGH Academy; Author, This Is Your Brain on Food (Little, Brown Spark; 2020).

The authors have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

After years of suggestive studies, the first randomized controlled to test a practical approach to diet in ADHD is out. Find out which foods to eat, and which to avoid.